Clinical trial

[18F]F-DOPA Imaging in Patients With Autonomic Failure

NCT04246437

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2020-02-04

PhasePHASE1

Study timeline

Study start (actual)2020-02-04Date precision: day

Registry last updated2026-03-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Autonomic Failureunresolved

Pure Autonomic Failureverified · MONDO: pure autonomic failure

Parkinson Diseaseverified · MONDO: Parkinson disease

Multiple System Atrophyverified · MONDO: multiple system atrophy

Dementia With Lewy Bodiesverified · MONDO: Lewy body dementia

Interventions

Carbidopa 200mg oral doseDRUG

Entacapone 400mg oral doseDRUG

Sponsors & collaborators

Daniel Claassenlead sponsor

Mapped research locations

NashvilleTennessee, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04246437 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.